Mohs Micrographic surgery for head and neck lesions: A six years single centre experience

Introduction: Mohs Micrographic surgery (MMS) was first reported by Fredrick Mohs in the 1940's as chemosurgery and later refined to its current state. This involves a combination of staged excision and comprehensive histological margin assessment. British Association of Dermatologists (BAD) recommend its use for high risk BCC's of the facial region. MMS offers a 99% 5-years cure rate for primary BCC's and 94.5% for recurrent lesions. Oral presentations for BAOMS Annual Scientific Meeting 2-4 July 2014, Edinburgh International Conference Centre, ScotlandBritish Journal of Oral and Maxillofacial SurgeryVol. 52Issue 8Preview Full-Text PDF